SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing intense scrutiny following a Q4 report that featured a double earnings beat but was overshadowed by a significant, disappointing guidance cut. While the community is actively debating whether the stock is undervalued at current levels or if the brand is suffering from weakened demand and increased competition, the broader sentiment remains cautious as investors weigh potential leadership changes and long-term growth prospects against immediate margin pressures.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors weigh a wave of regulatory progress, including recent DOE and NRC approvals, against the pressure of an upcoming earnings release. The community remains deeply polarized, with bulls focused on long-term data center partnerships and nuclear energy demand, while bears point to the company's pre-revenue status and significant insider selling as red flags.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing significant volatility driven by a short report from Muddy Waters, which alleges issues regarding accounting transparency and debt classification. While the firm's claims have sparked a sharp decline, the community is deeply divided, with many retail investors dismissing the allegations as a market manipulation tactic intended to provide liquidity for short-sellers and actively using the dip to increase their long positions.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently the center of active community debate following the filing for a new $1 billion at-the-market offering, which many investors are analyzing as a strategic move to bolster long-term funding despite recent volatility. While some participants express frustration over the timing of the announcement, others are framing the offering as a necessary step for capital-intensive growth, keeping the stock a major focal point for discussions on sector liquidity and future scaling.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is generating significant market buzz following its recent IPO as retail investors flock to the drone and autonomous defense software provider. The community is actively debating its high-growth potential and low-float volatility, with many traders drawing parallels to other explosive defense-tech runners while tracking its performance amid ongoing global geopolitical instability.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is currently facing intense volatility as the market reacts to a leaked memo from Publicis Groupe, which advised clients to cease using the platform following a contentious third-party audit. While the company has officially refuted these claims and the stock has drawn support from massive insider buying by the CEO, community sentiment remains deeply divided between those viewing the pullback as a calculated manipulation to secure shares at a discount and those concerned about the lack of a permanent CFO and mounting competitive pressure.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign shares are facing intense downward pressure as investors rotate out of the software sector, with many community members expressing frustration over consistent selling and concerns that generative AI could commoditize the firm's core digital agreement services. While some traders are attempting to buy the dip at multi-year lows, citing strong cash flow and potential short-squeeze opportunities, others remain skeptical about the stock's long-term competitive moat in an AI-dominated market.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing intense parabolic momentum driven by a combination of a structural AI-led memory supply shortage and a massive gamma squeeze that has left bearish traders scrambling. The community is sharply divided between those riding the historic rally and short-sellers who remain convinced the rapid, multi-day ascent will eventually lead to a significant correction.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending as investors digest the company's update on the FLAMINGO-01 trial, which reported that commercially manufactured GP2 is now being utilized across all U.S. clinical sites. The community remains hyper-focused on the upcoming release of AACR abstract titles, interpreting the full Steering Committee's co-authorship as a major signal of scientific confidence and a potential precursor to a significant partnership or buyout.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is surging to all-time highs as traders pile into calls and sentiment remains extremely bullish ahead of an earnings report, bolstered by the recent completion of a major Taiwan facility acquisition and news that HBM4 supply is largely booked through 2026. The community is intensely focused on whether this rally has already priced in an earnings blowout or if the stock's role as an indispensable AI infrastructure provider will trigger further upside toward the 500-level.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cantor Fitzgerald L. P. Invests $1.58 Million in Bicara Therapeutics Inc. $BCAX

Cantor Fitzgerald L. P. purchased a new position in shares of Bicara Therapeutics Inc. (NASDAQ:BCAX - Free Report) in the third quarter, according to its most recent disclosure with the Securities...

Bicara Therapeutics Talks Ficerasfusp Alfa Data, Pivotal Trial Timeline and $172M Raise at Conference

Bicara Therapeutics (NASDAQ:BCAX) is developing tumor-targeting bifunctional antibodies, with its lead candidate ficerasfusp alfa designed to address both EGFR and TGF-beta biology in cancer, company...

Bicara Therapeutics (NASDAQ:BCAX) CEO Sells $704,804.22 in Stock

Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CEO Claire Mazumdar sold 36,766 shares of the stock in a transaction dated Monday, March 9th. The shares were sold at an average price of...

Claire Mazumdar Sells 36,766 Shares of Bicara Therapeutics (NASDAQ:BCAX) Stock

Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CEO Claire Mazumdar sold 36,766 shares of the company's stock in a transaction on Monday, March 9th. The stock was sold at an average price of...

Bicara Therapeutics (NASDAQ:BCAX) Reaches New 1-Year High - Here's What Happened

Bicara Therapeutics (NASDAQ:BCAX) Sets New 1-Year High - Still a Buy...

Insider Selling: Bicara Therapeutics (NASDAQ:BCAX) CEO Sells 1,786 Shares of Stock

Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CEO Claire Mazumdar sold 1,786 shares of Bicara Therapeutics stock in a transaction that occurred on Thursday, March 5th. The shares were sold...

Bicara Therapeutics (NASDAQ:BCAX) CEO Sells $49,278.63 in Stock

Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CEO Claire Mazumdar sold 2,631 shares of the firm's stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of...

Bicara Therapeutics (NASDAQ:BCAX) CEO Sells $33,469.64 in Stock

Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CEO Claire Mazumdar sold 1,786 shares of the business's stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an...

Bicara Therapeutics (NASDAQ:BCAX) CEO Claire Mazumdar Sells 3,817 Shares

Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CEO Claire Mazumdar sold 3,817 shares of the stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price...

Ivan Hyep Sells 13,555 Shares of Bicara Therapeutics (NASDAQ:BCAX) Stock

Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CFO Ivan Hyep sold 13,555 shares of the business's stock in a transaction that occurred on Tuesday, March 3rd. The shares were sold at an...

Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and develops biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the power of tumor microenvironment modulators. The company’s bi-functional antibodies are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, offering the potential for synergistic therapeutic impact at the site of the tumor. Its products include BCA101, a first-in-class EGFR/TGF-ß-trap bifunctional antibody in clinical development for multiple tumor types. The company was founded on December 12, 2018 and is headquartered in Boston, MA.

Current Price	$19.32
Prev Close	$19.40
Open	$19.30
Dividend Yield	0.00%
50-Day Moving Average	$16.87
Beta	1.76
Avg. Volume	504,042.94
PE Ratio	-8.70

52-Week High	$20.25
52-Week Low	$7.80
Market Capitalization	$1.23B
EPS (Annual)	-$1.25
Price to Book	2.63
Revenue Per Employee	$0.00

BCAX
Bicara Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BCAX News

BCAXBicara Therapeutics